Trades on 1 secondary market

Variant Bio

Variant Bio is a biotechnology company developing life-saving therapies by studying the genes of people with exceptional health-related traits. Working with partner communities around the world under an ethical, benefit-sharing approach, the company pairs large-scale genomic discovery with data scie

minimal 9.3 / 100 0 APIs View provider profile →

Company Genomics Therapeutics Drug Discovery Biotechnology Precision Medicine

Variant Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.